RARA and neoplasm: These altered miRNAs might have contributed to the anti-tumor action of RARαS77A as well, thus explaining why miR-3074-5p’s target DHRS3 only partially counteracted RARαS77A-induced growth arrest, and more work is required before we can fully understand the interplay between RARα and these altered miRNAs.